Impact of objective response (OR) on patient-reported outcomes (PRO) in   patients (pts) with advanced breast cancer (ABC) and a germline BRCA1/2   (gBRCA) mutation in the phase III EMBRACA trial

Title:: Impact of objective response (OR) on patient-reported outcomes (PRO) in patients (pts) with advanced breast cancer (ABC) and a germline BRCA1/2 (gBRCA) mutation in the phase III EMBRACA trial
Document type:: Meeting Abstract
Author(s):: Fasching, P. A.; Quek, R. G. W.; Bhattacharyya, H.; Hurvitz, S. A.; Rugo, H. S.; Ettl, J.
Journal title abbreviation:: Ann Oncol
Year:: 2019
Journal volume:: 30 Suppl 3
Print-ISSN:: 0923-7534
TUM Institution:: Frauenklinik und Poliklinik
BibTeX

Occurrences: